Stockscreener 앱 받기
17.89
2.11%
0.3318
전일 마감가:
$17.56
열려 있는:
$17.52
하루 거래량:
816.93K
Relative Volume:
0.60
시가총액:
$882.66M
수익:
$224.45M
순이익/손실:
$-95.27M
주가수익비율:
-9.2704
EPS:
-1.93
순현금흐름:
$-43.74M
1주 성능:
+8.73%
1개월 성능:
-14.50%
6개월 성능:
-35.87%
1년 성능:
+0.90%
1일 변동 폭
$17.52
$18.44
1주일 범위
$15.59
$18.44
52주 변동 폭
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
명칭
Staar Surgical Co
전화
(626) 303-7902
주소
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.88 | 866.87M | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
498.08 | 177.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.45 | 51.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.78 | 40.42B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.41 | 39.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.41 | 37.72B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-03 | 개시 | Wedbush | Neutral |
| 2026-01-16 | 재개 | Morgan Stanley | Underweight |
| 2025-04-21 | 개시 | Wells Fargo | Equal Weight |
| 2025-02-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-02-12 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-05 | 다운그레이드 | Needham | Buy → Hold |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-09-15 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 개시 | Piper Sandler | Neutral |
| 2023-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-12-28 | 재확인 | BTIG Research | Buy |
| 2022-12-08 | 개시 | Stifel | Hold |
| 2022-11-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-28 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-07-09 | 개시 | Oppenheimer | Perform |
| 2021-01-19 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-10-26 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-31 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-08-06 | 재확인 | The Benchmark Company | Buy |
| 2020-07-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-06-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-06-15 | 개시 | Jefferies | Buy |
| 2019-12-04 | 개시 | BTIG Research | Buy |
| 2018-09-24 | 재확인 | The Benchmark Company | Buy |
| 2018-08-06 | 재개 | The Benchmark Company | Buy |
| 2017-11-20 | 재확인 | The Benchmark Company | Buy |
| 2017-08-14 | 재확인 | The Benchmark Company | Buy |
| 2017-03-03 | 재확인 | The Benchmark Company | Buy |
| 2016-05-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 재개 | The Benchmark Company | Buy |
| 2013-02-28 | 재확인 | The Benchmark Company | Buy |
| 2012-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 개시 | Northland Securities | Outperform |
| 2011-10-25 | 재확인 | The Benchmark Company | Buy |
| 2010-10-12 | 개시 | Morgan Joseph | Buy |
| 2010-05-11 | 개시 | Benchmark | Buy |
모두보기
Staar Surgical Co 주식(STAA)의 최신 뉴스
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs - Eyes On Eyecare
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years - Yahoo Finance
FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision Correction - VisionMonday.com
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens - Eyes On Eyecare
Midday Stock Roundup: Staar Surgical up on FDA approval - Orange County Business Journal
FDA expands age indication for Staar Surgical EVO ICL - MassDevice
Why Is Staar Surgical Stock Gaining Wednesday?Staar Surgical (NASDAQ:STAA) - Benzinga
Staar Surgical Gains Key FDA Approval to Broaden Patient Eligibility - AD HOC NEWS
FDA approved expanded age indication for EVO/EVO+ Visian implantable lenses - TipRanks
STAAR Surgical (STAA) Expands Lens Use with FDA Approval - GuruFocus
FDA expands U.S. age indication for EVO ICL - marketscreener.com
STAAR Surgical Company Announces FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away from Laser Vision Correction - marketscreener.com
New Alcon lens helps aging eyes stay in contacts all month - Stock Titan
Credit Industriel ET Commercial Invests $3.26 Million in STAAR Surgical Company $STAA - MarketBeat
New York Life Investment Management LLC Takes Position in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical Company (STAA) Stock Analysis: Exploring a 37.81% Potential Upside for Investors - DirectorsTalk Interviews
Alpine Associates Management Inc. Acquires Shares of 913,087 STAAR Surgical Company $STAA - MarketBeat
VIEW Optometry launches to support independent practices - Eyes On Eyecare
STAAR Surgical Company (NASDAQ:STAA) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
212,421 Shares in STAAR Surgical Company $STAA Acquired by Versor Investments LP - MarketBeat
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
STAAR Surgical (NASDAQ:STAA) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Staar Surgical price target lowered to $19 from $28 at Stifel - TipRanks
Leadership watch: Staar Surgical names co-CEOs, ACET adds to Board - Eyes On Eyecare
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns By Investing.com - Investing.com India
STAAR Surgical stock price target lowered to $19 by Stifel on China concerns - Investing.com Nigeria
Stifel Lowers Price Target for STAA; Maintains Hold Rating | STA - GuruFocus
Staar Surgical CoEnters agreement with Chief Legal Officer Nathaniel SisitskySEC filing - marketscreener.com
STAAR Surgical Company (STAA): A Bull Case Theory - Finviz
Staar Surgical initiated with a Neutral at Wedbush - TipRanks
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) - MSN
Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth - Finviz
STAA Receives Neutral Rating as Wedbush Initiates Coverage | STA - GuruFocus
STAAR names interim co-CEOs amid search for permanent leader - MedTech Dive
STAAR Surgical (NASDAQ:STAA) Now Covered by Wedbush - MarketBeat
STAAR Surgical (STAA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
STAAR Surgical Names Warren Foust and Deborah Andrews Interim Co-CEOs - VisionMonday.com
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Staar Surgical names interim co-CEOs in leadership shift following failed Alcon deal - massdevice.com
Why STAAR Surgical (STAA) Shares Are Down Today - Bitget
Why STAAR Surgical (STAA) Stock Is Trading Lower Today - Finviz
Staar Surgical Appoints Interim Co-CEOs - Orange County Business Journal
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs - PharmiWeb.com
New weekly contact lens offers Canadians 16 hours of daily comfort - stocktitan.net
Staar Surgical appoints Warren Foust & Deborah Andrews interim co-CEOs - marketscreener.com
STAAR Surgical Company Announces Interim Co-CEO Appointments, Effective February 1, 2026 - marketscreener.com
Staar Surgical (STAA) Appoints Interim Co-CEOs as CEO Search Beg - GuruFocus
A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders - Fierce Biotech
Staar Surgical Names Interim Co-CEOs Amid Leadership Transition - TipRanks
Staar Surgical appoints COO Warren Foust, CFO Deborah Andrews as interim co-CEOs - TipRanks
STAAR Surgical Company (STAA) Stock Analysis: Insights Into The 23.34% Potential Upside - DirectorsTalk Interviews
Staar Surgical Co (STAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.05%
자본화:
|
볼륨(24시간):